Anal Cancer
158
31
46
68
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
29 trials with published results (18%)
Research Maturity
68 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
10.8%
17 terminated out of 158 trials
80.0%
-6.5% vs benchmark
8%
12 trials in Phase 3/4
43%
29 of 68 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 68 completed trials
Clinical Trials (158)
Integrated Cancer Repository for Cancer Research
DESTINY-PANTUMOUR04
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
Self-sampling to Optimize Anal Lesion Outcomes
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy
Detecting HPV DNA in Anal and Cervical Cancers
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
HPV Genotype Attribution and Disease Burden of Anal Cancer in China
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors